| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Royalty Pharma Plc (RPRX) have been net sellers, shedding 219,254 shares worth roughly $13.0M on balance. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
RPRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.31M | - | - | |
| VP | 270.4K | $15.82M | - | |
| Dir | 196.3K | - | - | |
| Dir | 79.8K | $4.66M | - | |
| Dir | 58.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Urist Marshall73 | EVP, Research &Investments | Sell10b5-1 | 4,126 | $57.10 | $235,594.60 | -100% | - | - | |
| Sep 28, 2026 | Urist Marshall73 | EVP, Research &Investments | Sell10b5-1 | 4,126 | $57.88 | $238,812.88 | -50.0% | - | - | |
| Sep 22, 2026 | Hite Christopher | EVP &Chairman, Partnering | Sell10b5-1 | 100,000 | $58.53 | $5,853,095.18 | -27.0% | - | - | |
| Aug 18, 2026 | Hite Christopher | EVP &Chairman, Partnering | Sell10b5-1 | 100,000 | $59.97 | $5,997,250.00 | -21.3% | - | - | |
| Aug 13, 2026 | Coyne Terrance P.74 | EVP &CFO | Sell10b5-1 | 11,002 | $58.68 | $645,551.21 | -100% | - | - | |
| Jul 1, 2026 | Urist Marshall73 | EVP, Research &Investments | Sell10b5-1 | 9,099 | $55.88 | $508,453.94 | -100% | +4.4% | - | |
| Jun 30, 2026 | Hite Christopher | EVP &Chairman, Partnering | Sell10b5-1 | 130,000 | $56.50 | $7,345,470.79 | -20.7% | +4.1% | - | |
| Jun 24, 2026 | Urist Marshall73 | EVP, Research &Investments | Sell10b5-1 | 9,098 | $55.18 | $502,066.76 | -50.0% | +7.8% | - | |
| Jun 23, 2026 | Hite Christopher | EVP &Chairman, Partnering | Sell10b5-1 | 150,000 | $54.40 | $8,159,276.82 | -21.1% | +5.6% | - | |
| May 26, 2026 | Coyne Terrance P.74 | EVP &CFO | Sell10b5-1 | 64,399 | $53.98 | $3,476,116.34 | -100% | +13.9% | - |